Terri Cooper

Dr. Terri Cooper is the Chief Inclusion Officer for Deloitte Consulting LLP. In this role, she recruits, develops, and advances a diverse and inclusive workforce at Deloitte. Cooper is also the US National Chief Inclusion Leader for Deloitte Consulting and the LCSP for New York Presbyterian and Mount Sinai.

She leads the Global Healthcare Sector for Deloitte and is a principal in Deloitte Consulting. For more than two decades working in Life Sciences and Healthcare, she has participated in a broad range of strategic advisory services, including creating global business models, product development, regulatory affairs, mergers, marketing, product launches, and re-engineering information management processes.

Prior to joining Deloitte Consulting, Cooper worked in the pharmaceutical industry managing clinical development, regulatory affairs, sales, and marketing; and she has gained a broad range of experience in developing new products and obtaining product licenses in the UK and the U.S. In addition to her consulting work, she frequently participates in industry conferences, discussing inclusion in the workplace and evolving healthcare and life sciences trends, including emerging cognitive technologies that promise to transform healthcare significantly. Cooper's perspectives on these topics have appeared in the Harvard Business Review, Modern Healthcare, and other publications.

She serves on the Board of City Year NY, which places highly trained young people of all backgrounds full-time in schools as tutors, mentors and role models. Additionally, she is a member of the Board of The Friends of the Patients of the NIH, which provides emotional and financial support to the incredibly brave patients receiving groundbreaking and life-saving treatments at the NIH.

Cooper holds a Joint Honors Bachelor of Science degree in Chemistry and Pharmacology and a Ph.D. in Pharmacology from the University of London, UK.